Uric acid and xanthine oxidase: future therapeutic targets in the prevention of cardiovascular disease?

J Dawson, M Walters - British journal of clinical pharmacology, 2006 - Wiley Online Library
Serum uric acid may be an independent risk factor for cardiovascular disease. This review
examines this association, potential mechanisms, and explores whether strategies to reduce …

Uric acid reduction: a new paradigm in the management of cardiovascular risk?

J Dawson, T Quinn, M Walters - Current medicinal chemistry, 2007 - ingentaconnect.com
Uric acid is the end-product of purine catabolism. Hyperuricaemia is implicated in disorders
such as gout and urolithiasis and recent epidemiological evidence suggests an association …

The potential for xanthine oxidase inhibition in the prevention and treatment of cardiovascular and cerebrovascular disease

P Higgins, J Dawson, M Walters - … Psychiatry and Neurology, 2009 - Wiley Online Library
There is a now a wealth of epidemiological, animal, and clinical data to suggest the benefits
of uric acid reduction and hxanthine oxidase inhibition in prevention of vascular disease …

Uric acid: role in cardiovascular disease and effects of losartan

M Alderman, KJV Aiyer - Current medical research and opinion, 2004 - Taylor & Francis
SUMMARY A substantial body of epidemiological and experimental evidence suggests that
serum uric acid is an important, independent risk factor for cardiovascular and renal disease …

Uric acid lowering therapy in cardiovascular diseases

M Volterrani, F Iellamo, B Sposato, F Romeo - International Journal of …, 2016 - Elsevier
Recent evidence would indicate that high serum uric acid (SUA) levels can be a significant
and independent risk factor for hypertension and cardiovascular diseases, such as ischemic …

The role of urate and xanthine oxidase inhibitors in cardiovascular disease

J George, AD Struthers - Cardiovascular Drug Reviews, 2008 - Wiley Online Library
Many studies have shown a strong correlation between urate levels and cardiovascular
disease. The formation of urate is complex as the same enzyme that produces urate …

Xanthine oxidase and uric acid in cardiovascular disease: clinical impact and therapeutic options

W Doehner, U Landmesser - Seminars in nephrology, 2011 - Elsevier
The association between increased uric acid (UA) levels and cardiovascular disease (CVD)
has been observed and studied for many decades. The value of UA as an independent …

Urate-lowering drugs and prevention of cardiovascular disease: the emerging role of xanthine oxidase inhibition

C Borghi, G Desideri - Hypertension, 2016 - Am Heart Assoc
Borghi and Desideri Allopurinol and Cardiovascular Disease 497 the increase in the
endothelium-dependent forearm vasodilatation was enhanced by allopurinol in a dose …

Hyperuricemia and cardiovascular disease risk

C Borghi, FM Verardi, I Pareo… - Expert review of …, 2014 - Taylor & Francis
Uric acid (UA) is the final end product of purine catabolism and is formed from xanthines and
hypoxanthines. Hyperuricemia can be secondary to either an exaggerated production of UA …

Uric acid as a risk factor for cardiovascular disease

WS Waring, DJ Webb, SRJ Maxwell - Qjm, 2000 - academic.oup.com
Over recent years there has been renewed debate about the nature of the association
between raised serum uric acid concentration and cardiovascular disease. 1 Several large …